PL320916A1 - Derivatives of piperasino 2,5-dione as modulators of drug-fastness in respect to amny drugs - Google Patents

Derivatives of piperasino 2,5-dione as modulators of drug-fastness in respect to amny drugs

Info

Publication number
PL320916A1
PL320916A1 PL95320916A PL32091695A PL320916A1 PL 320916 A1 PL320916 A1 PL 320916A1 PL 95320916 A PL95320916 A PL 95320916A PL 32091695 A PL32091695 A PL 32091695A PL 320916 A1 PL320916 A1 PL 320916A1
Authority
PL
Poland
Prior art keywords
piperasino
amny
fastness
dione
modulators
Prior art date
Application number
PL95320916A
Other languages
English (en)
Inventor
Philip Anthony Ashworth
Sukhjit Hunjan
Ian Andrew Pretswell
Hamish Ryder
Stephen James Brocchini
Original Assignee
Xenova Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenova Ltd filed Critical Xenova Ltd
Publication of PL320916A1 publication Critical patent/PL320916A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL95320916A 1994-12-23 1995-12-22 Derivatives of piperasino 2,5-dione as modulators of drug-fastness in respect to amny drugs PL320916A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9426224.3A GB9426224D0 (en) 1994-12-23 1994-12-23 Pharmaceutical compounds
PCT/GB1995/003027 WO1996020190A1 (en) 1994-12-23 1995-12-22 Piperazine 2,5 dione derivatives as modulators of multi-drug resistance

Publications (1)

Publication Number Publication Date
PL320916A1 true PL320916A1 (en) 1997-11-10

Family

ID=10766589

Family Applications (1)

Application Number Title Priority Date Filing Date
PL95320916A PL320916A1 (en) 1994-12-23 1995-12-22 Derivatives of piperasino 2,5-dione as modulators of drug-fastness in respect to amny drugs

Country Status (19)

Country Link
EP (1) EP0799222A1 (no)
JP (1) JPH10511384A (no)
CN (1) CN1175253A (no)
AU (1) AU698828B2 (no)
BG (1) BG101602A (no)
BR (1) BR9510410A (no)
CA (1) CA2207500A1 (no)
CZ (1) CZ190097A3 (no)
FI (1) FI972660A (no)
GB (1) GB9426224D0 (no)
HU (1) HUT77943A (no)
IL (1) IL116525A0 (no)
NO (1) NO972937D0 (no)
NZ (1) NZ297847A (no)
PL (1) PL320916A1 (no)
SK (1) SK83697A3 (no)
TW (1) TW358094B (no)
WO (1) WO1996020190A1 (no)
ZA (1) ZA9510909B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9717576D0 (en) * 1997-08-19 1997-10-22 Xenova Ltd Pharmaceutical compounds
HUP0001531A3 (en) * 1996-10-18 2000-09-28 Xenova Ltd Slough Anthranilic acid derivatives as multi drug resistance modulators
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
DE69929704T2 (de) 1998-10-08 2006-07-20 Smithkline Beecham Plc, Brentford Tetrahydrobenzazepin-derivate verwendbar als dopamin-d3-rezeptor-modulatoren (antipsychotische mittel)
BRPI0017067B8 (pt) * 2000-01-18 2021-05-25 Beyondspring Pharmaceuticals Inc inibidor de divisão de célula, desidrogenase, método para a produção de um inibidor de divisão de célula e composto
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US7919497B2 (en) 2002-08-02 2011-04-05 Nereus Pharmaceuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
ES2295695T3 (es) 2002-08-02 2008-04-16 Nereus Pharmaceuticals, Inc. Deshidrofenilahistinas y sus analogos y la sintesis de deshidrofenilahistinas y sus analogos.
US7935704B2 (en) 2003-08-01 2011-05-03 Nereus Pharmaceuticals, Inc. Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
US8129527B2 (en) 2006-11-03 2012-03-06 Nereus Pharmacuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
CN103396372B (zh) * 2013-08-09 2015-05-20 中国科学院南海海洋研究所 一类2,5-二酮哌嗪衍生物及其制备方法和在制备抗海洋污损生物防除剂中的应用
BR112017018964A2 (pt) 2015-03-06 2018-05-22 Beyondspring Pharmaceuticals Inc uso de plinabulin e métodos para tratar tumor cerebral
RU2736045C2 (ru) 2015-03-06 2020-11-11 Бейондспринг Фармасьютикалс, Инк. Способ лечения рака, ассоциированного с мутацией ras
WO2017011399A1 (en) 2015-07-13 2017-01-19 Beyondspring Pharmaceuticals, Inc Plinabulin compositions
AU2017217426B2 (en) 2016-02-08 2022-12-01 Beyondspring Pharmaceuticals, Inc. Compositions containing tucaresol or its analogs
BR112018074990A2 (pt) 2016-06-06 2019-03-12 Beyondspring Pharmaceuticals, Inc. composição, usos e método para reduzir neutropenia
CN110431135A (zh) 2017-01-06 2019-11-08 大连万春布林医药有限公司 微管蛋白结合化合物及其治疗用途
US11400086B2 (en) 2017-02-01 2022-08-02 Beyondspring Pharmaceuticals, Inc. Method of reducing chemotherapy-induced neutropenia
EP3743074A4 (en) 2018-01-24 2021-12-15 Beyondspring Pharmaceuticals Inc. COMPOSITION AND METHOD FOR REDUCING THROMBOCYTOPENIA BY THE ADMINISTRATION OF PLINABULINE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0649410B1 (en) * 1992-07-10 1997-05-02 Laboratoires Glaxo Sa Anilide derivatives
GB9217331D0 (en) * 1992-08-14 1992-09-30 Xenova Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
CN1175253A (zh) 1998-03-04
CA2207500A1 (en) 1996-07-04
FI972660A0 (fi) 1997-06-19
ZA9510909B (en) 1996-08-30
BG101602A (en) 1998-02-27
NZ297847A (en) 1999-04-29
GB9426224D0 (en) 1995-02-22
EP0799222A1 (en) 1997-10-08
WO1996020190A1 (en) 1996-07-04
HUT77943A (hu) 1998-12-28
FI972660A (fi) 1997-08-22
IL116525A0 (en) 1996-03-31
SK83697A3 (en) 1998-05-06
AU4310096A (en) 1996-07-19
JPH10511384A (ja) 1998-11-04
NO972937L (no) 1997-06-23
CZ190097A3 (cs) 1998-01-14
NO972937D0 (no) 1997-06-23
AU698828B2 (en) 1998-11-05
BR9510410A (pt) 1999-09-08
TW358094B (en) 1999-05-11

Similar Documents

Publication Publication Date Title
PL320916A1 (en) Derivatives of piperasino 2,5-dione as modulators of drug-fastness in respect to amny drugs
GR3032486T3 (en) 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol derivatives as pharmaceutical agents
HUP0000474A3 (en) Arylethenesulfonamide derivatives and drug composition containing the same
HUP9901086A3 (en) Arylsulfonylaminobenzene derivatives, pharmaceutical compositions containing them and their use for producing pharmaceutical compositions
IL113196A0 (en) Imidazole derivatives and pharmaceutical compositions containing the same
IL116851A (en) 3-arylidene-2-oxindole derivatives and pharmaceutical compositions containing them
IL112384A0 (en) Tetracyclic derivatives, their preparation and pharmaceutical compositions containing them
IL111314A0 (en) Indole derivatives, their preparation and pharmaceutical compositions containing them
ZA968945B (en) 1,3-Dihydro-indol-2-one derivatives process for their preparation and the pharmaceutical compositions containing them
HUP9900881A3 (en) 4,5-diaryl oxazole derivatives and pharmaceutical compositions containing them
IL109234A0 (en) Indole derivatives, their preparation and pharmaceutical compositions containing them
HUP9802937A3 (en) Benzo[g]quuinoline derivatives, pharmaceutical compositions containing them and their use
IL108859A0 (en) Indole derivatives, their preparation and pharmaceutical compositions containing them
HUP9901096A3 (en) Indole derivatives, preparation and use thereof, pharmaceutical composition containing these compounds
HUP9802290A3 (en) Pyrrole derivatives and pharmaceutical compositions containing them
IL111294A0 (en) Indole derivatives, their preparation and pharmaceutical compositions containing them
IL110980A0 (en) Indole derivatives, their preparation and pharmaceutical compositions containing them
HUP9901336A3 (en) Heteroaryl-substituted acryloylguanidine derivatives and medicinal composition thereof
HUP9901485A2 (en) Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use
HUP9801386A3 (en) Indazolecarboxamide derivatives, preparation thereof and pharmaceutical compositions containing them
IL118427A (en) N-acyl-2 aryl cycloalkylmethylamine derivatives as melatonergics and pharmaceutical compositions comprising them
GB9614452D0 (en) Improvements relating to pharmaceutical cartons
HUP9801158A3 (en) Imidazole derivatives and medicinal composition thereof
IL117224A (en) 1,2,5-thiadiazole derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines and antimigraine pharmaceutical compositions comprising them
HUP9800631A3 (en) 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions